May 5 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- REVIEWING & CONSIDERING INFORMATION CONTAINED IN HEALIUS TARGET’S STATEMENT WITH ITS ADVISERS
- ACL'S OFFER FOR HEALIUS IS OPEN FOR ACCEPTANCE UNTIL 7.00PM (SYDNEY TIME) ON 29 SEPT
- NOTES HEALIUS IDENTIFIES NUMBER OF CONDITIONS OF OFFER THAT IT CONSIDERS ARE NOT LIKELY TO BE SATISFIED
News: HLS Australian Clinical Labs Says Reviewing Healius' Target's Statement
Add to My Watchlist
What is My Watchlist?